Nephrotic syndrome and liver cirrhosis are common clinical manifestations, and are associated with avid sodium retention leading to the development of edema and ascites. However, the mechanism for the sodium retention is still incompletely understood and the molecular basis remains undefined. We examined the changes of sodium (co)transporters and epithelial sodium channels (ENaCs) in the kidneys of experimental nephrotic syndrome and liver cirrhosis. The results demonstrated that puromycin-or HgCl2?induced nephrotic syndrome was associated with 1) sodium retention, decreased urinary sodium excretion, development of ascites, and increased plasma aldosterone level; 2) increased apical targeting of ENaC subunits in connecting tubule and collecting duct segments; and 3) decreased protein abundance of type 2 11β-hydroxysteroid dehydrogenase (11βHSD2). Experimental liver cirrhosis was induced in rats by CCl4 treatment or common bile duct ligation. An increased apical targeting of alpha-, beta-, and gamma-ENaC subunits in connecting tubule, and cortical and medullary collecting duct segments in sodium retaining phase of liver cirhosis but not in escape phase of sodium retention. Immunolabeling intensity of 11βHSD2 in the connecting tubule and cortical collecting duct was significantly reduced in sodium retaining phase of liver cirrhosis, and this was confirmed by immunoblotting. These observations therefore strongly support the view that the renal sodium retention associated with nephrotic syndrome and liver cirrhosis is caused by increased sodium reabsorption in the aldosterone sensitive distal nephron including the connecting tubule and collecting duct, and increased apical targeting of ENaC subunits plays a role in the development of sodium retention in nephrotic syndrome and liver cirrhosis. De p a r t me n to fI n t
HgCl2?induced nephrotic syndrome was associated with 1) sodium retention, decreased urinary sodium excretion, development of ascites, and increased plasma aldosterone level; 2) increased apical targeting of ENaC subunits in connecting tubule and collecting duct segments; and 3) decreased protein abundance of type 2 11β-hydroxysteroid dehydrogenase (11βHSD2). Experimental liver cirrhosis was induced in rats by CCl4 treatment or common bile duct ligation. An increased apical targeting of alpha-, beta-, and gamma-ENaC subunits in connecting tubule, and cortical and medullary collecting duct segments in sodium retaining phase of liver cirhosis but not in escape phase of sodium retention. Immunolabeling intensity of 11βHSD2 in the connecting tubule and cortical collecting duct was significantly reduced in sodium retaining phase of liver cirrhosis, and this was confirmed by immunoblotting. These observations therefore strongly support the view that the renal sodium retention associated with nephrotic syndrome and liver cirrhosis is caused by increased sodium reabsorption in the aldosterone sensitive distal nephron including the connecting tubule and collecting duct, and increased apical targeting of ENaC subunits plays a role in the development of sodium retention in nephrotic syndrome and liver cirrhosis.
Ke y Wo r d s: Edema, Sodium retention, Epithelial sodium channel, Aldosterone sensitive distal nephron 4) Even though sodium transport occurs along the entire length of the tubule, the fine regulation in sodium reabsorption is primarily seen in the late distal tubule including the connecting tubule and collecting duct.
This regulation is mainly mediated by local hormones such as aldosterone, vasopressin and angiotensin II which induced epithelial sodium channel (ENaC) activation [1] [2] [3] [4] [5] [6] [7] [8] .
In the rat kidney, the three homologous subunits (α, β, and γ) that constitute the functional ENaC protein are detected in the late distal convoluted tubule (DCT2), connecting tubule (CNT), cortical collecting C o r r e s p o n d e n c ea u t h o r : S o oWa nKi m, M. D. De p a r t me n to fI n t e r n a lMe d i c i n eMe d i c i n e ,C h o n n a m Na t i o n a l Un i v e r s i t yMe d i c a lS c h o o l , Gwa n g j u , Ko r e a Te l : 0 6 2 ) 2 2 0 -6 2 7 2 F a x: 0 6 2 ) 2 2 5 -8 5 7 8 E -ma i l :s k i mw@c h o n n a m. a c . k r duct (CCD), and outer medullary collecting duct (OMCD), and to a lesser extent, the inner medullary collecting duct (IMCD) [1] [2] [3] . It has been shown that α-ENaC is mainly present at the apical domains of the principal cells, whereas β-and γ-ENaC are mainly associated with intracellular vesicles dispersed in the entire cytoplasm 1) . The physiological significance of the heterogeneity in the subcellular localization of the three sub-units has not been established. The α-subunit is functional when expressed alone in Xenopus laevis oocyte, but channel activity is highly increased by association with β-and γ-subunits 4) . The generation of gene knockouts of the individual subunits in mice demonstrated that altered expression of any of the three subunits has significant effects on multimeric ENaC protein sodium transport capacity 5) . Regulation of sodium reaborption by ENaC mediated by hormones such as aldosterone and vasopressin is associated with characteristic alterations in the expression of the individual ENaC subunits 6, 7) . Chronic aldosterone infusion in rats increases the protein abundance of α-ENaC. Moreover, aldosterone causes a mobility shift of γ-ENaC from an 85-kDa band to 70-kDa band 8) .
Chronic vasopressin infusion results in significantly increased abundances of all three ENaC subunits 6) . The apical plasma membrane expression of ENaC can also be altered by changes in the trafficking of the channel subunits to the apical plasma membrane. Under sodium-replete conditions, when aldosterone levels are low ENaC immunostaining of CCD revealed diffuse labeling throughout the principal cells, consistent with localization in a vesicular pool. In contrast, sodium restriction or aldosterone infusion caused a dramatic redistribution of ENaC to the apical membrane 7, 8) .
These results suggest that not only protein abundance but also translocation of ENaC to the apical plasma membrane are under the tight control.
The regulation of sodium transport in the distal nephron is paramount for the regulation volume and electrolyte balance in the body. In the collecting duct, electrogenic entry of sodium from the lumen into the cells is mediated by ENaC located in the apical plasma membrane 9) . This represents the rate-limiting step for sodium absorption and is characterized by inhibition with submicromolar concentrations of the diuretic amiloride 10) . Thus, ENaC is a critically important final regulator of the balance between intake and excretion of dietary sodium, and along with the thiazide-sensitive NaCl co-transporter constitutes the predominant sodium transport systems in the aldosterone-sensitive distal nephron.
Nephrotic syndrome and liver cirrhosis are mainly associated with avid sodium retention leading to the development of edema and ascites. However, the mechanism for the sodium retention is still incompletely understood and the molecular basis remains undefined. This review aims at providing recent insight into the role of ENaC and sodium (co)transporters in the kidney in sodium retentive disease such as nephrotic syndrome and liver cirrhosis. . Thus, this study directly point to a role of increased sodium reabsorption in the collecting duct and, hence, it may be hypothesized that dysregulation of the key sodium channels and transporters in the collecting duct may be responsible for this. A few studies have subsequently demonstrated that sodium retention in PAN nephrotic rats is correlated with increased Na,K-ATPase activity and expression in the cortical collecting duct 12, 13) .
We demonstrated that PAN-induced nephrotic syndrome is associated with 1) sodium retention, decreased urinary excretion of sodium, a marked ascites, and increased plasma aldosterone level, 2) upregulation of protein abundance of specific ENaC subunits in cortex, outer medulla and inner medulla, and 3) increased apical targeting of ENaC subunits in connecting tubule and collecting duct segments observed as increased immunolabeling in apical plasma membrane domains 14) .
In contrast, the protein levels of other major sodium transporters expressed in nephron segments at a site proximal to the connecting tubule (i.e., NHE3, NKCC2, Na,K-ATPase and NCC) were significantly reduced in these segments 14) . Indeed, there was no downregulation of the Na,K-ATPase expression in the collecting duct. Taken together, these observations therefore strongly support the view that the renal sodium retention associated with PAN-induced nephrotic syndrome is caused by increased sodium reabsorption in connecting tubule and collecting duct 14) .
Thus, this is likely to represent a key molecular basis for the sodium retention associated with PAN-induced nephrotic syndrome combined with the previously demonstrated increase in collecting duct Na,KATPase activity and protein abundance 12, 13) . Moreover, our results extend this study by demonstrating the segmental specific upregulation of all three ENaC subunits, and most importantly provide evidence for a significantly increased apical targeting by immunoelectron microscopy. The latter is essential since it is important to document that the increased expression is at the site of function i.e. in the plasma membrane. . Thus, a straightforward interpretation of these observations would be that increased apical targeting of ENaC subunits plays a role in the development of sodium retention in HgCl2 nephrotic syndrome as well, and it could be argued that this mechanism in fact could be a general characteristic of the nephrotic syndrome including both minimal change disease and immune complex mediated glomerulonephritis.
Apical targeting of ENaC subunits and protein abundance of αENaC can be regulated by aldosterone 7, 8) . Indeed, plasma aldosterone levels were significantly increased in HgCl2 nephropathy, and thus, it can be speculated that aldosterone stimulate the sodium reabsorption in HgCl2 nephropathy. However, substantial evidence argue against a major role of aldosterone in nephrotic syndrome : 1) ascites and edema occur in rats with nephrosis attributable to rabbit anti-rat kidney serum injection, without elevated aldosterone levels 19) . 2) inhibition of angiotensin converting enzyme by captopril failed to induce natriuresis in rats with PAN nephrosis despite decreased aldosterone levels 20) . and 3) sodium retention was observed only in the affected proteinuria kidney in rats unilateral models of PAN nephrosis 11) . These observations suggest that aldosterone may not alone be involved in the sodium retention and presumably in the ENaC regulation in the nephrotic syndrome.
It has been suggested that the activity of type 2 11β
hydroxysteroid dehydrogenase (11βHSD2) can regulate the sodium reabsorption in the aldosterone responsive renal tubules by glucocorticoid induced activation of mineralocorticoid receptor (MR) 21) . We also demonstrate that there is a downregulation of 11βHSD2 protein expression in the kidney in HgCl2 nephrotic syndrome as well as in PAN nephrosis. This finding is in line with recent studies in nephrotic patients 22) and in experimental nephrotic syndrome induced by PAN or adriamycin 23) . The investigators observed a rise in the plasma ratio of corticosterone/11-dehydrocorticosterone as well as in the urinary ratio of (THB＋5α -THB)/ THA in nephritic rats 23) , and interpreted this change as a result of a decreased activity of 11β -hydroxysteroid dehydrogenase. We here propose that this may occur via a downregulated protein expression of 11βHSD2 in nephrotic syndrome. These findings suggest that downregulation of 11βHSD2 provides access of glucocorticoids to the MR, resulting in increased activity of MR and collecting duct sodium retention in rats with nephrotic syndrome.
Systemic and local factors are known to regulate
ENaC abundance, targeting and activity as well as Na,K-ATPase activity. These include aldosterone 7, 8) , vasopressin 6) and angiotensin II (ANG II) 24) . Aldosterone is known to increase Na,K-ATPase activity in the cortical collecting duct and to increase ENaC redistribution to the apical membrane of connecting tubule and collecting duct principal cells and to promote the expression of a 70 kDa form of the gamma ENaC subunit, thought to be linked to activation of the channel by proteolytic cleavage 7, 8) . It is therefore tempting to link this hormone with the findings observed in PAN nephrosis. Moreover levels of vasopressin, ANG II and aldosterone are increased in the initial phase of nephrosis 14, 25, 26) , leading to the hypothesis that they may play significant roles in the de- . The situation is less clear for aldosterone. There have been contradictory studies on the impact of aldosterone absence on the development of edema in nephrotic syndrome 28, 29) .
Furthermore, even though pharmacologic blockade of aldosterone has been proven to be unsuccessful regarding sodium retention in experimental nephrosis 15) , this cannot rule out aldosterone effect as pharmacologic mineralocorticoid receptor blockade has been demonstrated to be useless against ENaC trafficking 30) and would not avoid aldosterone action through the glucocorticoid receptor 31) . Finally, Na,K-ATPase in the collecting duct of nephrotic rats is still activated in the absence of aldosterone 29) . However nothing is known about ENaC regulation in that condition. It is therefore not known whether the enhanced ENaC targeting observed in PAN nephrosis is a primary dysregulation in nephrotic syndrome or is secondary to the high aldosterone levels observed in this condition.
We therefore studied the development of nephrotic syndrome in adrenalectomized rats, aiming at defining the role of aldosterone on sodium retention and ENaC However, the underlying molecular and cellular mechanisms for the sodium retention are still incompletely understood. In particular, the role of aldosterone in sodium retention and ascites formation in liver cirrhosis is still unclear. Previous studies demonstrated that plasma aldosterone levels were usually elevated in liver cirrhosis with ascites 33) and that spironolactone, a mineralocorticoid receptor antagonist, increased sodium excretion in these patients 34) .
This suggests that hyperaldosteronism is of major importance in the pathogenesis of sodium retention.
There has been some controversy as to the role of regulation of the renal sodium transporters and channels in the development of edema in animal models of cirrhosis. There are two major rat models of liver cirrhosis. In the first, rats are treated with carbon tetrachloride (CCl4) in combination with Phenobarbital supplied in the drinking water, which results in liver toxicity. In the second, rats have their common bile duct ligated, and increased circulating levels of bile acids (cholestasis) results in hepatotoxicity and eventually cirrhosis. Differences in the severity, reproducibility, and rapidity of the manifestation of ascites in the two models probably play a role in some discrepancies 35) .
CCl4 induced liver cirrhosis
The renal responses for sodium retention displayed wide variations among the rats with CCl4-induced liver cirrhosis. Some rats showed markedly decreased urinary sodium excretion (sodium retaining stage, group A) whereas the others exhibited unchanged urinary sodium excretion (maintenance stage, group B) compared with controls, even though all CCl4-treated rats had significant amount of ascites (Fig. 3)  36 ) . The .
We demonstrated that the abundance of βENaC was decreased or unchanged, and the abundance of the 70-kDa form of γENaC was increased while the 85-kDa band was markedly decreased in the sodiumretaining stage (group A) of cirrhotic rats (Fig. 4) 36)
.
Previous studies demonstrated that aldosterone causes a mobility shift of γENaC from an 85 kDa band to 70 kDa band without a change in total γENaC protein abundance 7) . The same changes are observed in chronically sodium-restricted rats in addition to a significant downregulation of the βENaC subunit 7) . Thus, the observed increased apical targeting and altered expression of β-and γENaC subunits in group A could be caused by the stimulation of mineralocorticoid receptor (MR) in the aldosterone-responsive epithelium.
Common bile duct ligation (CBDL) induced-biliary liver cirrhosis
Long-term bile duct ligation in rats is a well known experimental model of liver cirrhosis and portal hypertension, and has been widely used to study the renal mechanisms of sodium retention, as well as systemic and splanchnic hemodynamics 38) . CBDL rats showed . These findings may suggest that there are dynamic changes in sodium retention at different stages (i.e., a sodium retaining stage and a compen- . Loss of function mutation of 11βHSD2 or inhibition of 11βHSD2 activity allows glucocortiocids to promote renal sodium retention and potassium excretion in the cortical collecting tubule 40, 41) . These findings suggest that the 11βHSD2
regulates the sodium reabsorption in the aldosterone responsive renal tubules by glucocorticoid-induced activation of the MR. We demonstrate in the present studies that there is downregulation of 11βHSD2 abundance in the kidney in decompensated liver cirrhosis rats. This finding is in line with recent studies in compensated liver cirrhosis reported by Quattropani et al. 42) and Escher et al. 43) . They demonstrated that 11β HSD2 activity in the kidney was reduced in liver cirrhosis following bile duct ligation 42, 43) . These findings together suggest that reduced expression and activity provides basis for access of glucocorticoids to the MR, thereby promoting increased collecting duct sodium reabsorption despite normal plasma levels of aldosterone in rats with experimental liver cirrhosis.
This notion was strongly supported by the increased apical targeting of ENaC subunits in rats with glycyrrhizic acid-induced inhibition of 11βHSD2 activity 44) .
Plasma aldosterone levels, at least in humans and rats without liver cirrhosis, have been shown to be reduced in conditions with low expression of 11βHSD2 40, 41) . It is noteworthy that plasma aldosterone levels
were not reduced in 6 wk liver cirrhosis rats, despite that the protein abundance of 11βHSD2 was significantly decreased. Thus, coordinated activation of MR by both glucocorticoid as a consequence of reduced activity of 11βHSD2 and by relatively high plasma aldosterone may enhance distal renal tubular sodium reabsorption and potassium loss, and hence play important roles for the pathogenesis of sodium retention and possible ascites formation in CBDL-induced liver cirrhosis. In contrast, in response to liver cirrhosis for 8 weeks ENaC abundance was decreased (Fig. 6 ) and the reduction was associated with decreased plasma aldosterone levels 39) . In addition, the increased apical targeting of ENaC subunits was retrieved in spite of decreased abundance of 11βHSD2. It can be speculated that 11βHSD2 is still functioning but not at full power (thus aldosterone may play a major role), or it may be speculated that differences in ENaC trafficking between 6 and 8 weeks are independent of aldosterone and/or 11βHSD2.
In normal rats both the apical targeting and protein abundance of αENaC are increased by high dose aldosterone treatment 7) . However, in the present study we did not observe an increase in αENaC protein expression in the cortex in kidneys from rats with CBDL-induced liver cirrhosis for 6 weeks although aldosterone dissociates more slowly from MR than cortisol does, indicating that the stability of the aldosterone-MR complex is higher than that of the cortisol-MR complex 45, 46) . In addition, the MR activity can be regulated by at the level of transcription activation or repression by cell specific co-factors 47) .
It is also interesting to note that the rats with liver cirrhosis apparently exhibited dynamic changes in sodium retention and ENaC trafficking. 
